Literature DB >> 26214519

Emerging roles for macrophages in cardiac injury: cytoprotection, repair, and regeneration.

Nikolaos G Frangogiannis.   

Abstract

The mammalian heart contains a population of resident macrophages that expands in response to myocardial infarction through the recruitment of monocytes. Infarct macrophages exhibit high phenotypic diversity and respond to microenvironmental cues by altering their functional properties and secretory profile. In this issue of the JCI, de Couto and colleagues demonstrate that infiltrating macrophages can be primed to acquire a cardioprotective phenotype in ischemic heart and exert this proactive effect through activation of an antiapoptotic program in cardiomyocytes. This study supports the growing body of evidence that suggests that macrophage subpopulations can be modulated to mediate cytoprotective, reparative, and even regenerative functions in the infarcted heart. The cellular mechanisms and molecular signals driving these macrophage phenotypes are yet unknown; however, harnessing the remarkable potential of the macrophage in regulating cell survival and tissue regeneration may hold therapeutic promise for myocardial infarction.

Entities:  

Mesh:

Year:  2015        PMID: 26214519      PMCID: PMC4563767          DOI: 10.1172/JCI83191

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.

Authors:  Elaine Wan; Xin Yi Yeap; Shirley Dehn; Rachael Terry; Margaret Novak; Shuang Zhang; Shinichi Iwata; Xiaoqiang Han; Shunichi Homma; Konstantinos Drosatos; Jon Lomasney; David M Engman; Stephen D Miller; Douglas E Vaughan; John P Morrow; Raj Kishore; Edward B Thorp
Journal:  Circ Res       Date:  2013-07-08       Impact factor: 17.367

2.  MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype.

Authors:  Nikolaos G Frangogiannis; Leonardo H Mendoza; Guofeng Ren; Spyridon Akrivakis; Peggy L Jackson; Lloyd H Michael; C Wayne Smith; Mark L Entman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-10       Impact factor: 4.733

3.  Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction.

Authors:  Timo Heidt; Gabriel Courties; Partha Dutta; Hendrik B Sager; Matt Sebas; Yoshiko Iwamoto; Yuan Sun; Nicolas Da Silva; Peter Panizzi; Anja M van der Laan; Anja M van der Lahn; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circ Res       Date:  2014-05-01       Impact factor: 17.367

4.  Macrophages are required for neonatal heart regeneration.

Authors:  Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

5.  Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation.

Authors:  Slava Epelman; Kory J Lavine; Anna E Beaudin; Dorothy K Sojka; Javier A Carrero; Boris Calderon; Thaddeus Brija; Emmanuel L Gautier; Stoyan Ivanov; Ansuman T Satpathy; Joel D Schilling; Reto Schwendener; Ismail Sergin; Babak Razani; E Camilla Forsberg; Wayne M Yokoyama; Emil R Unanue; Marco Colonna; Gwendalyn J Randolph; Douglas L Mann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

6.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

7.  Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction.

Authors:  Stefan Frantz; Ulrich Hofmann; Daniela Fraccarollo; Andreas Schäfer; Stefanie Kranepuhl; Ina Hagedorn; Bernhard Nieswandt; Matthias Nahrendorf; Helga Wagner; Barbara Bayer; Christina Pachel; Michael P Schön; Susanne Kneitz; Tobias Bobinger; Frank Weidemann; Georg Ertl; Johann Bauersachs
Journal:  FASEB J       Date:  2012-11-16       Impact factor: 5.191

Review 8.  Breakthroughs in cell therapy for heart disease: focus on cardiosphere-derived cells.

Authors:  Eduardo Marbán
Journal:  Mayo Clin Proc       Date:  2014-06       Impact factor: 7.616

9.  Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium.

Authors:  Ingo Hilgendorf; Louisa M S Gerhardt; Timothy C Tan; Carla Winter; Tobias A W Holderried; Benjamin G Chousterman; Yoshiko Iwamoto; Ronglih Liao; Andreas Zirlik; Marielle Scherer-Crosbie; Catherine C Hedrick; Peter Libby; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Circ Res       Date:  2014-03-13       Impact factor: 17.367

10.  Inflammation and ischemia: macrophages activated by fibronectin fragments enhance the survival of injured cardiac myocytes.

Authors:  JoAnn Trial; Roger D Rossen; Jose Rubio; Anne A Knowlton
Journal:  Exp Biol Med (Maywood)       Date:  2004-06
View more
  20 in total

1.  Macrophages in the Remodeling Failing Heart.

Authors:  Bijun Chen; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-09-16       Impact factor: 17.367

2.  Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction.

Authors:  Maria Cimini; Venkata Naga Srikanth Garikipati; Claudio de Lucia; Zhongjian Cheng; Chunlin Wang; May M Truongcao; Anna Maria Lucchese; Rajika Roy; Cindy Benedict; David A Goukassian; Walter J Koch; Raj Kishore
Journal:  JCI Insight       Date:  2019-07-09

Review 3.  Possible Muscle Repair in the Human Cardiovascular System.

Authors:  Linda Sommese; Alberto Zullo; Concetta Schiano; Francesco P Mancini; Claudio Napoli
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

Review 4.  Myocardial infarction remodeling that progresses to heart failure: a signaling misunderstanding.

Authors:  Alan J Mouton; Osvaldo J Rivera; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-30       Impact factor: 4.733

5.  Infant cardiosphere-derived cells exhibit non-durable heart protection in dilated cardiomyopathy rats.

Authors:  Siyuan Wang; Weidan Chen; Li Ma; Minghui Zou; Wenyan Dong; Haili Yang; Lei Sun; Xinxin Chen; Jinzhu Duan
Journal:  Cytotechnology       Date:  2019-10-03       Impact factor: 2.058

Review 6.  Immunomodulation by Exosomes in Myocardial Infarction.

Authors:  Wen Pan; Yujiao Zhu; Xiangmin Meng; Chenlin Zhang; Yan Yang; Yihua Bei
Journal:  J Cardiovasc Transl Res       Date:  2018-10-29       Impact factor: 4.132

7.  Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction.

Authors:  Alison K Schroer; Matthew R Bersi; Cynthia R Clark; Qinkun Zhang; Lehanna H Sanders; Antonis K Hatzopoulos; Thomas L Force; Susan M Majka; Hind Lal; W David Merryman
Journal:  JCI Insight       Date:  2019-09-19

8.  Reg-ulating macrophage infiltration to alter wound healing following myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Cardiovasc Res       Date:  2018-10-01       Impact factor: 13.081

9.  The association of systemic inflammatory markers with indicators of stress and cardiac necrosis in patients undergoing aortic valve replacement and revascularization surgeries.

Authors:  A Saracevic; I Medved; S Hrabric Vlah; A Kozmar; L Bilic-Zulle; A M Simundic
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

Review 10.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.